The Impact of Comorbid Nasal Polyps on Real-World Mepolizumab Effectiveness in Patients with Severe Asthma: Results from the REALITI-A Study

被引：0
|
作者：
Liu, M. C. [1 ,2 ]
Bagnasco, D. [3 ]
Matucci, A. [4 ]
Pilette, C. [5 ,6 ]
Price, R. G. [7 ]
Maxwell, A. C. [8 ]
Cristancho, R. Alfonso [9 ]
Jakes, R. W. [10 ]
Yang, S. [9 ]
Howarth, P. [11 ]
Cheema, A. S. [12 ]
机构：
[1] Johns Hopkins Asthma & Allergy Ctr, Div Clin Immunol & Allergy, Baltimore, MD USA
[2] Johns Hopkins Asthma & Allergy Ctr, Div Pulm & Crit Care Med, Baltimore, MD USA
[3] Univ Genoa, Osped Policlin San Martino, DIMI Dept Internal Med, Allergy & Resp Dis, Genoa, Italy
[4] Univ Florence, Azienda Osped Univ Careggi, Immunoallergol Unit, Florence, Italy
[5] UCLouvain, Clin Univ St Luc, Dept Pulm Med, Brussels, Belgium
[6] UCLouvain, Inst Expt & Clin Res, Brussels, Belgium
[7] GSK, Biostat, Stevenage, Herts, England
[8] GSK, Real World Study Delivery, Value Evidence & Outcomes, Global Med, Stevenage, Herts, England
[9] GSK, Value Evidence & Outcomes, Collegeville, PA USA
[10] GSK, Epidemiol, London, England
[11] GSK, Specialty Care TA, Global Med, Brentford, England
[12] Alpha Med Res, Mississauga, ON, Canada
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4837
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The impact of comorbid nasal polyps on real-world mepolizumab effectiveness in patients with severe asthma: Results from the REALITI-A study
    Liu, Mark C.
    Bagnasco, Diego
    Matucci, Andrea
    Pilette, Charles
    Price, Robert G.
    Maxwell, Aoife C.
    Alfonso-Cristancho, Rafael
    Jakes, Rupert W.
    Yang, Shibing
    Howarth, Peter
    Cheema, Amarjit S.
    ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (06) : 566 - 566
  • [2] The Impact of Comorbidities and Clinical Characteristics on Real-World Mepolizumab Effectiveness in Patients with Severe Asthma: Results from the REALITI-A Study
    Chupp, G. L.
    Heaney, L. G.
    Pelaia, G.
    Welte, T.
    Sanchez, C. Almonacid
    Lee, J. K.
    Maxwell, A.
    Price, R. G.
    Jakes, R. W.
    Cristancho, R. Alfonso
    Howarth, P.
    Brusselle, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [3] Real-world effectiveness of mepolizumab in patients with asthma and comorbid nasal polyps
    Ou, Ming-Che
    Tsai, Ru-Yin
    Li, Chen-Pi
    Gau, Shuo-Yan
    Chang, Hui-Chin
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06)
  • [4] Real-world outcomes with mepolizumab in patients with severe asthma and comorbid anxiety/depression: REALITI-A at 2 years
    Chaudhuri, Rekha
    Liu, Mark C.
    Bagnasco, Diego
    Matucci, Andrea
    Pilette, Charles
    Price, Robert G.
    Demetriou, Lydia
    Howarth, Peter
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [5] Real World Benefits of Mepolizumab in Patients With Severe Asthma and Comorbid Chronic Rhinosinusitis With Nasal Polyps (CRSwNP): Post Hoc Analysis of REALITI-A
    Lee, Frances
    Liu, Mark
    Bagnasco, Diego
    Matucci, Andrea
    Pilette, Charles
    Price, Robert
    Alfonso-Cristancho, Rafael
    Jakes, Rupert
    Howarth, Peter
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB15 - AB15
  • [6] National Differences in Real-World Outcomes with Mepolizumab Treatment for Patients with Severe Asthma: Results from the REALITI-A Study
    Lee, J. K.
    Schleich, F.
    Canonica, G. W.
    Munoz, X.
    Chaudhuri, R.
    Lee, F. E.
    Howarth, P.
    Price, R. G.
    Yang, S.
    Jakes, R. W.
    Maxwell, A.
    Cristancho, R. Alfonso
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [7] Real-world mepolizumab in the prospective severe asthma REALITI-A study: initial analysis
    Harrison, Tim
    Canonica, Giorgio Walter
    Chupp, Geoffrey
    Lee, Jason
    Schleich, Florence
    Welte, Tobias
    Valero, Antonio
    Gemzoe, Kim
    Maxwell, Aoife
    Joksaite, Sandra
    Yang, Shibing
    Howarth, Peter
    Van Dyke, Melissa K.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (04)
  • [8] International, prospective real-world study of mepolizumab in patients with severe asthma at one year: REALITI-A
    Pilette, Charles
    Canonica, Giorgio Walter
    Chaudhuri, Rekha
    Lee, F. Eun-Hyung
    Lee, Jason Kihyuk
    Sanchez, Carlos Almonacid
    Alfonso-Cristancho, Rafael
    Jakes, Rupert
    Maxwell, Aoife
    Price, Robert
    Howarth, Peter
    ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (06) : 566 - 566
  • [9] Real-World Benefits of Mepolizumab in Patients With Severe Asthma and Comorbid GERD or Anxiety/Depression: Post Hoc Analysis of REALITI-A
    Liu, Mark
    Bagnasco, Diego
    Matucci, Andrea
    Pilette, Charles
    Price, Robert
    Maxwell, Aoife
    Alfonso-Cristancho, Rafael
    Jakes, Rupert
    Lee, Jason
    Cheema, Amarjit
    Howarth, Peter
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB20 - AB20
  • [10] Effectiveness and safety of mepolizumab in real-world clinical practice: The REALITI-A study
    Harrison, T.
    Canonica, G.
    Gemzoe, K.
    Maxwell, A.
    Yang, S.
    Joksaite, S.
    O'Reilly, R.
    Van Dyke, M.
    Albers, F. C.
    Kwon, N.
    PNEUMOLOGIE, 2020, 74 : S25 - S25
12345